A RANDOMIZED CONTROLLED TRIAL OF N-ACETYL CYSTEINE AS A NEUROPROTECTIVE AGENT IN PROGRESSIVE MS
$2,234,976FY2021Defense Health AgencyDOD
Regents Of The University Of California, San Francisco, The
Regents Of The University Of California, San Francisco, The